Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
23.46
+0.05 (0.21%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Janux Therapeutics Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$76.55
Upside
+226.30%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Initiates $47 | Buy | Initiates | $47 | +100.34% | Sep 17, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +326.26% | Sep 10, 2025 |
| Stifel | Stifel | Strong Buy Initiates $45 | Strong Buy | Initiates | $45 | +91.82% | Sep 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $72 | Strong Buy | Initiates | $72 | +206.91% | Sep 4, 2025 |
| Piper Sandler | Piper Sandler | Buy Initiates $42 | Buy | Initiates | $42 | +79.03% | Aug 19, 2025 |
| Raymond James | Raymond James | Buy Initiates $65 | Buy | Initiates | $65 | +177.07% | Jul 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $70 | Strong Buy | Reiterates | $70 | +198.38% | Mar 3, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $62 → $41 | Hold | Maintains | $62 → $41 | +74.77% | Feb 28, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $200 | Buy | Reiterates | $200 | +752.51% | Dec 11, 2024 |
| Scotiabank | Scotiabank | Hold Maintains $42 → $62 | Hold | Maintains | $42 → $62 | +164.28% | Dec 4, 2024 |
| Stifel | Stifel | Strong Buy Maintains $70 → $115 | Strong Buy | Maintains | $70 → $115 | +390.20% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $79 → $91 | Buy | Maintains | $79 → $91 | +287.89% | Dec 3, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $70 | Strong Buy | Maintains | $63 → $70 | +198.38% | Dec 3, 2024 |
| Leerink Partners | Leerink Partners | Buy Initiates $79 | Buy | Initiates | $79 | +236.74% | Nov 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +168.54% | Nov 7, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +326.26% | Nov 7, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.